In video 1 of this three-part series, learn about the relevance of real-world evidence in COPD with underlying type 2 inflammation and how it can complement phase 3 clinical trial findings, with pulmonologist Dr. Mustafa Abdo.
In video 2 of this three-part series, learn about the rationale for a German real-world study of dupilumab in patients with COPD and underlying type 2 inflammation, and how it aims to complement clinical trial evidence, with pulmonologist Dr. Mustafa Abdo.
Join Professors Matthias Augustin and Sarina Elmariah for an engaging ADVENT symposium as they explore the pivotal role of type 2 inflammation in prurigo nodularis and chronic itch.